Clin2
NCT06996314Possibly a fitNot yet recruiting

Ear nerve stimulation with slow breathing for POTS

Postural Orthostatic Tachycardia Syndrome (POTS)Post-acute COVID-19 Syndromes

Part of Brain & nervous system, Infections, Lungs & breathing clinical trials.

This trial tests a relaxing technique that uses a small earpiece device to stimulate a nerve while you pace your breathing. It may help people with POTS by calming the nervous system and reducing symptoms like dizziness and fatigue.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must have a formal POTS diagnosis (confirmed by a doctor) and symptoms for at least 6 months.
  • Your POTS medication must be stable (same dose) for at least 4 weeks before joining.
  • You cannot have significant high blood pressure or a drop in blood pressure when standing.
  • You must not have had a stroke or heart attack in the past 6 months.
  • You cannot be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07026643Not yet recruiting
New nerve treatment for POTS symptoms

This study tests a new treatment (called aVNT) for people with POTS, a condition that causes a rapid heart rate when standing up. It aims to see if this treatment can help reduce symptoms and improve daily functioning.

NCT07163130Not yet recruiting
Ear stimulation for POTS treatment

This study tests if a gentle electrical stimulation near the ear (called tragus stimulation) can help with POTS symptoms, like dizziness and rapid heartbeat when standing. It aims to see if this non-invasive method can improve your daily life.

NCT06936319Recruiting
Body movements for POTS symptom control

This study tests simple body movements (like squeezing your legs or squatting) to see if they help control POTS symptoms. It may offer a non-drug way to manage dizziness and fast heart rate when standing.

Innsbruck, Tyrol
NCT07585513Not yet recruiting· Phase 2
Beta-blocker-like treatment for POTS

This study tests whether a daily pill called mirabegron can help control the rapid heartbeat and other symptoms of postural orthostatic tachycardia syndrome (POTS). If you join, you'll take the study drug or a placebo for a set time and track your symptoms.

NCT07019519Recruiting
Gut hormones and blood flow in POTS

This study looks at how gut hormones control blood flow after eating in people with POTS. It may help explain symptoms like dizziness and rapid heartbeat after meals.

Copenhagen
NCT04271878Recruiting
Test breathing and blood-pressure response in POTS patients

This study measures how breathing patterns and heart rate/blood pressure change when you move from lying to standing in people with POTS. It may help researchers understand symptoms better and improve ways to manage them.

Calgary, Alberta

Hear when a new Postural Orthostatic Tachycardia Syndrome (POTS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.